United States · 
Who invested in ImmunGene?
ImmunGene's investors include Ally Bridge Group.
United States · Series A startup
Who invested in ImmunGene
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow ImmunGene and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$9.0Mraised across 1 round since 2013, from 1 source
- Latest round
- Series A, $9.0MNov 2013
- Investors
- 1
The rounds
- Nov 2013
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ImmunGene
How much has ImmunGene raised?
ImmunGene has raised $9.0M across 1 round since 2013.
When did ImmunGene last raise?
ImmunGene's most recent round was a Series A of $9.0M in Nov 2013.
What was ImmunGene's biggest round?
Its most recent round, $9.0M in Nov 2013, is also its largest on record.
Who backed ImmunGene first?
ImmunGene's first round on record, in Nov 2013, was backed by Ally Bridge Group.
What stage is ImmunGene at?
ImmunGene's latest named round is a Series A, in Nov 2013.
Where is ImmunGene based?
ImmunGene is based in the United States.
Companies like ImmunGene
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.